Tavneos (avacopan)
pCPA File Number:
22437
Negotiation Status:
Active Negotiation
Indication(s):
Antineutrophil cytoplasmic antibody-associated vasculitis
Sponsor/Manufacturer:
Otsuka Canada Pharmaceutical Inc.
CDA-AMC Project Number:
SR0732-000
pCPA Engagement Letter Issued:
Negotiation Process Concluded:
Not Applicable